Klinikum rechts der Isar der TU München; Klinikapotheke

München 81675

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Carcinoma, Hepatocellular, Renal Cell Carcinoma

Studies at this site

• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma — Completed
• A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma — Completed